Q4 2014 13F Holders as of 31 Dec 2014
-
Type / Class
-
Equity / Common Shares, $0.001 par value
-
Shares outstanding
-
15,447,782
-
Number of holders
-
36
-
Total 13F shares, excl. options
-
4,658,068
-
Shares change
-
-333,234
-
Total reported value, excl. options
-
$48,527,188
-
Value change
-
-$3,469,757
-
Number of buys
-
15
-
Number of sells
-
-10
-
Price
-
$10.42
Significant Holders of Gabelli Healthcare & WellnessRx Trust - Common Shares, $0.001 par value (GRX) as of Q4 2014
36 filings reported holding GRX - Gabelli Healthcare & WellnessRx Trust - Common Shares, $0.001 par value as of Q4 2014.
Gabelli Healthcare & WellnessRx Trust - Common Shares, $0.001 par value (GRX) has 36 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 4,658,068 shares
of 15,447,782 outstanding shares and own 30% of the company stock.
Largest 10 shareholders include MORGAN STANLEY (1,518,730 shares), First Allied Advisory Services, Inc. (662,504 shares), RAYMOND JAMES & ASSOCIATES (506,591 shares), CREDIT SUISSE AG/ (329,543 shares), ROYAL BANK OF CANADA (249,005 shares), Thomas J. Herzfeld Advisors, Inc. (232,013 shares), GAMCO INVESTORS, INC. ET AL (215,942 shares), WELLS FARGO & COMPANY/MN (149,256 shares), MetLife Securities, Inc (105,730 shares), and LAZARD ASSET MANAGEMENT LLC (105,249 shares).
This table shows the top 36 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.